Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• MicroRNA-21 (miR-21) is a known oncomiR implicated in various cancers, including multiple myeloma (MM).
• Elevated miR-21 levels are frequently observed in MM patients, suggesting a critical role in disease progression.

Purpose of the Study:

• To investigate the specific functions of miR-21 in human MM cells.
• To identify direct molecular targets of miR-21 involved in MM pathogenesis.
• To elucidate the mechanism by which miR-21 contributes to MM development.

Main Methods:

• Knockdown of endogenous miR-21 in U266 myeloma cells.
• Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based quantitative proteomics to identify miR-21 targets.
• Western blotting and reporter gene assays to validate direct miR-21 targets.
• Analysis of the miR-21-STAT3 signaling pathway.

Main Results:

• Inhibition of miR-21 in MM cells led to reduced cell growth, cell cycle arrest, and increased apoptosis.
• Proteomic analysis identified 178 proteins significantly upregulated upon miR-21 inhibition, indicating potential miR-21 targets.
• Protein inhibitor of activated STAT3 (PIAS3) was confirmed as a direct target of miR-21.
• miR-21 was shown to enhance the STAT3 signaling pathway by inhibiting PIAS3, contributing to MM cell oncogenesis.

Conclusions:

• miR-21 plays a crucial role in promoting MM cell proliferation and survival.
• PIAS3 is a direct target of miR-21, and its down-regulation is essential for miR-21's oncogenic function in MM.
• The miR-21-PIAS3-STAT3 regulatory loop is a key mechanism in MM pathogenesis.
• Targeting the miR-21-PIAS3 interaction presents a promising therapeutic strategy for multiple myeloma.